Ownership history in FARALLON CAPITAL MANAGEMENT LLC · 7 quarters on record
This page tracks every 13F SEC filing in which FARALLON CAPITAL MANAGEMENT LLC reported a position in BRIDGEBIO PHARMA INC (BBIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 8,998,463 | +806,463 | +9.8% | 3.25% | $688.3M | $76.49 |
| 2025 Q3 | ADDED | 8,192,000 | +292,000 | +3.7% | 1.74% | $425.5M | $51.94 |
| 2025 Q2 | ADDED | 7,900,000 | +2,169,000 | +37.8% | 1.47% | $341.1M | $43.18 |
| 2025 Q1 | ADDED | 5,731,000 | +1,536,000 | +36.6% | 1.10% | $198.1M | $34.57 |
As of 2025 Q4 — sorted by position size